TOP - August 2015, Vol 8, No 3
“Considering the frequency of both pediatric cancer survivorship and of late toxicities related to treatment, childhood cancer is often the cancer diagnosis that lasts a lifetime.” Read More ›
Section 529 college savings plans are tax-advantaged college savings vehicles, and one of the most popular ways to save for college today. Read More ›
By Chase Doyle
Sunitinib and pazopanib have long battled for supremacy in treating advanced renal-cell carcinoma (RCC). According to findings presented at the National Comprehensive Cancer Network 20th Annual Conference, the newer drug, pazopanib, may have some benefit in total cost of care; survival outcomes were the same between drugs. Read More ›
Michael Koraleski, PharmD, outlined the proposed standards of the newest US Pharmacopeial Convention (USP) Chapter 800 at the 11th annual Hematology/Oncology Pharmacy Association conference. Read More ›
Dr Papadopoulou and colleagues conducted a study evaluating treatment and prevention of medication associated ONJ, and presented their findings. Read More ›
Page 2 of 2
- 1
- 2